Eurofins Central Laboratory Expands U.S. Lab Operations to Eurofins campus in Lancaster, PA
Lancaster, PA - 10 June 2014
Eurofins Central Laboratory is pleased to announce that is has achieved an important strategic milestone with the expansion and relocation of its U.S. Central Laboratory Operations to the 330,000 square foot Eurofins Pharma Services campus in Lancaster, PA. The consolidation of the Central Laboratory into the Lancaster Laboratories campus, combined with the recently announced acquisitions of leading bioanalytical, discovery, genomic and diagnostic laboratories in the US, positions Eurofins as a leading full service laboratory provider to the pharmaceutical and biotech industries. This purpose built Central Laboratory is essential to the Eurofins Central Laboratory global footprint of wholly-owned laboratory facilities in the United States, Europe, Asia and China. Read the full press release.